Mofebutazone

Clinical data
ATC code	M01AA02 (WHO) M02AA02 (WHO)
Identifiers
IUPAC name 4-butyl-1-phenylpyrazolidine-3,5-dione
CAS Number	2210-63-1 Y
PubChem CID	16639
ChemSpider	15776 N
UNII	SPW36WUI5Z
KEGG	D07262 Y
ChEBI	CHEBI:76252 N
CompTox Dashboard (EPA)	DTXSID4023331
ECHA InfoCard	100.016.947
Chemical and physical data
Formula	C13H16N2O2
Molar mass	232.283 g·mol−1
3D model (JSmol)	Interactive image
SMILES CCCCC1C(=O)NN(C1=O)c2ccccc2
InChI InChI=1S/C13H16N2O2/c1-2-3-9-11-12(16)14-15(13(11)17)10-7-5-4-6-8-10/h4-8,11H,2-3,9H2,1H3,(H,14,16) N Key:REOJLIXKJWXUGB-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Mofebutazone (or monophenylbutazone) is a drug used for joint and muscular pain.^[1][2] It is a 3,5-pyrazolinedione derivative.

The drug binds to plasma albumin and competes with drugs such as coumarin anticoagulants, indomethacin and glucocorticoids.